论文标题
Deep Kronecker网络
Deep Kronecker Network
论文作者
论文摘要
我们提出了Deep Kronecker Network(DKN),这是一个用于分析医学成像数据的新型框架,例如MRI,fMRI,CT等。医学成像数据与至少两个方面的一般图像不同:i)通常更有限,II)模型解释比结果预测更多。由于其独特的性质,很难直接应用一般方法,例如卷积神经网络(CNN)。因此,我们提出了DKN,可以i)适应低样本量限制,ii)提供所需的模型解释,iii)实现了CNN的预测能力。 DKN是一般的,因为它不仅适用于矩阵和(高阶)张量代表图像数据,而且可以应用于离散和连续结果。 DKN建立在Kronecker产品结构上,并隐式地对系数施加了分段光滑的属性。此外,Kronecker结构可以写成卷积形式,因此DKN也类似于CNN,尤其是完全卷积网络(FCN)。此外,我们证明,使用交替的最小化算法,即使目标函数高度不合格,DKN的解决方案也可以在几何上融合到真相。有趣的是,DKN还高度连接到Zhou等人提出的张量回归框架。 (2010年),其中candecomp/parafac(CP)低级结构施加在张量系数上。最后,我们使用来自阿尔茨海默氏病神经影像学计划(ADNI)的实际MRI数据进行分类和回归分析,以证明DKN的有效性。
We propose Deep Kronecker Network (DKN), a novel framework designed for analyzing medical imaging data, such as MRI, fMRI, CT, etc. Medical imaging data is different from general images in at least two aspects: i) sample size is usually much more limited, ii) model interpretation is more of a concern compared to outcome prediction. Due to its unique nature, general methods, such as convolutional neural network (CNN), are difficult to be directly applied. As such, we propose DKN, that is able to i) adapt to low sample size limitation, ii) provide desired model interpretation, and iii) achieve the prediction power as CNN. The DKN is general in the sense that it not only works for both matrix and (high-order) tensor represented image data, but also could be applied to both discrete and continuous outcomes. The DKN is built on a Kronecker product structure and implicitly imposes a piecewise smooth property on coefficients. Moreover, the Kronecker structure can be written into a convolutional form, so DKN also resembles a CNN, particularly, a fully convolutional network (FCN). Furthermore, we prove that with an alternating minimization algorithm, the solutions of DKN are guaranteed to converge to the truth geometrically even if the objective function is highly nonconvex. Interestingly, the DKN is also highly connected to the tensor regression framework proposed by Zhou et al. (2010), where a CANDECOMP/PARAFAC (CP) low-rank structure is imposed on tensor coefficients. Finally, we conduct both classification and regression analyses using real MRI data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) to demonstrate the effectiveness of DKN.